Logo
Login
$LXEO
$2.87 +$0.17 (6.3%) Close

Company Executives

$LXEO Management Team

Mr. Louis Tamayo

Chief Financial Officer

Principal Accounting Officer

Age 49
Compensation -
Sex Male

Dr. Jose Otero

Chief Operating Officer

Age 46
Compensation $3.555M USD
Sex Male

Dr. Sandi See Tai

Chief Development Officer

Age 54
Compensation -
Sex Female

Dr. Steven Altschuler

Independent Chairman of the Board

Age 71
Compensation $299.8K USD
Sex Male

Mr. R. Nolan Townsend

Chief Executive Officer

Director

Age 45
Compensation $4.375M USD
Sex Male

Ms. Jenny Robertson

Chief Legal Officer

Age 51
Compensation $1.297M USD
Sex Female

Dr. Narinder Bhalla

Chief Medical Officer

Age -
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 30, 2026
Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
Not stated
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Mette Kirstine Agger
Not stated Not stated Independent
Audit Committee Nominating and Corporate Governance Committee · Chair
None stated $140,861
Steven Altschuler
Not stated Not stated Independent
Compensation Committee Science and Technology Committee
None stated $163,361
Paula HJ Cholmondeley
Not stated Not stated Independent
Audit Committee · Chair
None stated $140,975
Brenda Cooperstone
Not stated Not stated Independent
Nominating and Corporate Governance Committee Science and Technology Committee · Chair
None stated $139,361
Reinaldo Diaz
Not stated Not stated Independent
Audit Committee Compensation Committee · Chair
None stated $140,861
Laura Sepp-Lorenzino
Not stated Not stated Independent
Science and Technology Committee
None stated Not stated
Toga Tanguler
Not stated Not stated Independent
Compensation Committee
None stated Not stated
Tim Van Hauwermeiren
Not stated Not stated Independent
Nominating and Corporate Governance Committee
None stated $120,579
R. Nolan Townsend
CEO
 Not stated Not stated Not independent None stated None stated Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

1 disclosed in the proxy filed Apr 30, 2026
Dr. Eric Adler
former Chief Medical Officer and Head of Research and an executive officer; co-founder of Stelios and a selling shareholder
Approximately $1.3 million
third quarter of 2024

Share of the milestone payment to the selling shareholders of Stelios under the July 16, 2021 acquisition of Stelios by the company.

With Stelios Therapeutics Inc. Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans